Corvus Pharmaceuticals Inc

NASDAQ:CRVS 4:00:00 PM EDT

1.51

-0.02 (-1.31%)

4:01:09 PM EDT: $1.47 -0.04 (-2.65%)

Corvus Pharmaceuticals Inc Stock, NASDAQ:CRVS

863 Mitten Road, Suite 102, Burlingame, California 94010

United States of America

Phone: +1.650.900.4520

Number of Employees: 28

http://www.corvuspharma.com

Description

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in Burlingame, CA.